Literature DB >> 19028687

PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion.

L Andy Chen1, Jing Li, Scott R Silva, Lindsey N Jackson, Yuning Zhou, Hiroaki Watanabe, Kirk L Ives, Mark R Hellmich, B Mark Evers.   

Abstract

The protein kinase D (PKD) family of serine/threonine kinases, which can be activated by gastrointestinal hormones, consists of three distinct isoforms that modulate a variety of cellular processes including intracellular protein transport as well as constitutive and regulated secretion. Although isoform-specific functions have been identified in a variety of cell lines, the expression and function of PKD isoforms in normal, differentiated secretory tissues is unknown. Here, we demonstrate that PKD isoforms are differentially expressed in the exocrine and endocrine cells of the pancreas. Specifically, PKD3 is the predominant isoform expressed in exocrine cells of the mouse and human pancreas, whereas PKD1 and PKD2 are more abundantly expressed in the pancreatic islets. Within isolated mouse pancreatic acinar cells, PKD3 undergoes rapid membrane translocation, trans-activating phosphorylation, and kinase activation after gastrointestinal hormone or cholinergic stimulation. PKD phosphorylation in pancreatic acinar cells occurs viaaCa2+-independent, diacylglycerol- and protein kinase C-dependent mechanism. PKD phosphorylation can also be induced by physiologic concentrations of secretagogues and by in vivo stimulation of the pancreas. Furthermore, activation of PKD3 potentiates MEK/ERK/RSK (RSK, ribosomal S6 kinase) signaling and significantly enhances cholecystokinin-mediated pancreatic amylase secretion. These findings reveal a novel distinction between the exocrine and endocrine cells of the pancreas and further identify PKD3 as a signaling molecule that promotes hormone-stimulated amylase secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028687      PMCID: PMC2629096          DOI: 10.1074/jbc.M801697200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC.

Authors:  T Chiu; E Rozengurt
Journal:  Am J Physiol Cell Physiol       Date:  2001-04       Impact factor: 4.249

2.  Protein kinase C mu selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway.

Authors:  A Hausser; P Storz; S Hübner; I Braendlin; M Martinez-Moya; G Link; F J Johannes
Journal:  FEBS Lett       Date:  2001-03-09       Impact factor: 4.124

3.  Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.

Authors:  Sushovan Guha; Osvaldo Rey; Enrique Rozengurt
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

4.  Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane.

Authors:  Carole L Baron; Vivek Malhotra
Journal:  Science       Date:  2001-11-29       Impact factor: 47.728

5.  Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin.

Authors:  B Ji; Y Bi; D Simeone; R M Mortensen; C D Logsdon
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

Review 6.  Protein kinase D: an intracellular traffic regulator on the move.

Authors:  Johan Van Lint; An Rykx; Yusuke Maeda; Tibor Vantus; Sabine Sturany; Vivek Malhotra; Jackie R Vandenheede; Thomas Seufferlein
Journal:  Trends Cell Biol       Date:  2002-04       Impact factor: 20.808

7.  Protein kinase C(mu) regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase C(epsilon).

Authors:  Ilona Brändlin; Tim Eiseler; Rüdiger Salowsky; Franz-Josef Johannes
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

8.  Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury.

Authors:  Richard T Ethridge; Dai H Chung; Michele Slogoff; Richard A Ehlers; Mark R Hellmich; Srinivasan Rajaraman; Hiroshi Saito; Tatsuo Uchida; B Mark Evers
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway.

Authors:  Peter Storz; Alex Toker
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

10.  Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain.

Authors:  Y Maeda; G V Beznoussenko; J Van Lint; A A Mironov; V Malhotra
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

View more
  22 in total

1.  Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.

Authors:  Sara M Johnson; Pat Gulhati; Isela Arrieta; Xiaofu Wang; Tatsuo Uchida; Tianyan Gao; B Mark Evers
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

Review 2.  Protein kinase D enzymes: novel kinase targets in pancreatic cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 3.869

3.  Age-dependent reduction of the PI3K regulatory subunit p85α suppresses pancreatic acinar cell proliferation.

Authors:  Hitoshi Takahashi; Daiki Okamura; Marlene E Starr; Hiroshi Saito; B Mark Evers
Journal:  Aging Cell       Date:  2012-02-01       Impact factor: 9.304

Review 4.  PKD signaling and pancreatitis.

Authors:  Jingzhen Yuan; Stephen J Pandol
Journal:  J Gastroenterol       Date:  2016-02-15       Impact factor: 7.527

5.  A novel protein kinase D inhibitor attenuates early events of experimental pancreatitis in isolated rat acini.

Authors:  Edwin C Thrower; Jingzhen Yuan; Ashar Usmani; Yannan Liu; Courtney Jones; Samantha N Minervini; Martine Alexandre; Stephen J Pandol; Sushovan Guha
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-14       Impact factor: 4.052

Review 6.  Molecular and cellular regulation of pancreatic acinar cell function.

Authors:  Sohail Husain; Edwin Thrower
Journal:  Curr Opin Gastroenterol       Date:  2009-09       Impact factor: 3.287

7.  In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.

Authors:  Jianxia Guo; Dana M Clausen; Jan H Beumer; Robert A Parise; Merrill J Egorin; Karla Bravo-Altamirano; Peter Wipf; Elizabeth R Sharlow; Qiming Jane Wang; Julie L Eiseman
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-30       Impact factor: 3.333

8.  PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.

Authors:  Zhipeng Zou; Fangyin Zeng; Wanfu Xu; Chunxia Wang; Zhiyong Ke; Q Jane Wang; Fan Deng
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

9.  Raf-1 kinase inhibitory protein (RKIP) mediates ethanol-induced sensitization of secretagogue signaling in pancreatic acinar cells.

Authors:  Sung Ok Kim; Kirk L Ives; Xiaofu Wang; Robert A Davey; Celia Chao; Mark R Hellmich
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

10.  Pancreas-specific deletion of protein kinase D attenuates inflammation, necrosis, and severity of acute pancreatitis.

Authors:  Jingzhen Yuan; Chintan Chheda; Honit Piplani; Meng Geng; Grace Tan; Reetu Thakur; Stephen J Pandol
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-10-09       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.